The runner began the challenge from his hometown of Vilnius, where pandemic travel restrictions confined his attempt to flat, asphalt-covered streets and parks. Each day started around 5 AM and ended by 7 PM, sustained through ambient temperatures that swung from minus 22 degrees Celsius to plus 33. His resting metabolic rate, measured before the challenge by indirect calorimetry, was 1,502 kilocalories, and during the run he consumed an average of roughly 5,800 kilocalories per day—about 45 percent from carbohydrates, 37 percent from fat, and 18 percent from protein, or more than 4 grams of protein per kilogram of body weight daily. Dividing his daily energy intake by his resting metabolic rate yielded a metabolic scope of approximately 3.86, the largest ever sustained in a human for more than a year. Remarkably, he achieved this on ordinary home-cooked meals and restaurant dinners supplemented by sports gels, bars, chocolates and doughnuts rather than an elite engineered nutrition program, tolerating more than 600 grams of carbohydrate per day with superior glucose handling documented in pre-challenge testing.

The musculoskeletal consequences were profound. Body mass dropped by about 3 kilograms in the first weeks—most of it fat, with only an estimated 0.6 kilograms of lean tissue lost—then stabilised for the remainder of the challenge before rebounding above baseline during recovery. Ultrasound imaging showed quadriceps muscle thickness shrinking by roughly 2 to 5 millimetres across both legs, and neuromuscular testing revealed declines far steeper than the modest weight loss would predict. Vertical jump height and power fell by 35 to 50 percent, and voluntary and electrically evoked isometric and isokinetic knee torques dropped by about 25 percent by the end of the challenge. The reactive strength index, a measure of stretch-shortening cycle performance during jumping, collapsed from 0.80 to 0.25 and had not returned to baseline even 17 months after the final step. Crucially, central activation of the knee extensors remained at 100 percent throughout, indicating that the deficits were peripheral—rooted in the muscle and tendon themselves—rather than a failure of the nervous system to recruit the muscles.

Blood biomarkers told a story of chronic, incomplete muscle damage. Serum creatine kinase, an enzyme released when muscle fibre membranes are disrupted, peaked at 15 times baseline just 30 days into the challenge and, although it declined over the following months, remained roughly threefold above baseline for the rest of the event—a sustained signal that the runner’s quadriceps were never fully recovering between daily sessions. Serum urea and the transaminases ALT and AST stayed two to three times above normal, most likely of muscular rather than hepatic origin. At the same time, plasma malondialdehyde, a marker of lipid peroxidation, rose alongside total antioxidant capacity, painting a picture of sustained oxidative stress met by a compensatory upregulation of antioxidant defences. Circulating IGF-1, an anabolic hormone central to muscle repair, was reduced at most sampling points, while growth differentiation factor 8—also known as myostatin, a powerful inhibitor of muscle growth—increased. Yet testosterone, often suppressed in extreme endurance contexts, remained within the normal range and generally above baseline, a fact the authors attribute to the absence of severe energy deficiency thanks to the athlete’s disciplined fuelling.

Muscle biopsies taken from the vastus lateralis two hours after the final 10-kilometre run, and again at one, ten and seventeen months into recovery, exposed the cellular underpinnings of this decline. Immediately after the challenge, protein markers of autophagy (LC3A/B-I), apoptosis (caspase-3) and inflammatory signalling (NF-κB p65) were elevated, while components of the electron transport chain and regulators of mitochondrial quality control—DRP1, PARKIN and MFN2—were at their lowest, with PARKIN later climbing roughly eightfold during recovery. The researchers interpret this as impaired mitochondrial turnover and diminished oxidative capacity at the challenge’s end, contributing to the observed atrophy and weakness. Perhaps most striking was the fibre-type composition: nearly 98 percent or more of the myosin heavy chain in the vastus lateralis was type I, an almost pure slow-twitch profile that reflects both genetic predisposition and a lifetime of endurance training, and which was likely essential to sustaining the daily mileage—while simultaneously explaining why power and jump performance, which depend on fast-twitch fibres, fell so dramatically and recovered so slowly.

The injury toll was substantial but, in the end, not prohibitive. By the midpoint of the challenge, ultrasound revealed a painful tibial stress reaction in the left leg—so severe that physicians advised pausing the run to avoid progression to a complete fracture—alongside iliotibial band bursitis in both legs. Over the ensuing months, mild tendinosis of the patellar and semitendinosus tendons, pes anserinus bursitis, partial tendon tears, thickened plantar fascia, and increasingly visible tears in both medial menisci appeared or worsened. The athlete persisted through the pain, which gradually resolved; by the end of the challenge, no acute lesions were detectable. Earlier in the run he had lost all his toenails to rainy weather, suffered a toe infection and ulceration from snowy paths, endured two episodes of severe diarrhoea, and experienced two episodes of amnesia in which he struggled for days to recall his running routes and associated activities. Three teeth were lost within six months after the challenge, with periodontitis suspected. Yet he avoided respiratory infections, required no medications, and maintained blood glucose between 3.8 and 5.8 millimoles per litre throughout.

Iron status emerged as one of the persistent vulnerabilities. Despite intravenous infusions before the challenge and on day 56, plus continuous oral supplementation, ferritin declined early and remained low for the rest of the run, indicating iron deficiency without overt anaemia—haemoglobin and red blood cell counts stayed within normal limits. The research team notes that some degree of iron compromise may be inevitable in challenges of this magnitude, even with aggressive supplementation. Echocardiography showed only a slight enlargement of left ventricular diastolic diameter, with no major changes in cardiac structure or function, and no pathological findings in other organs apart from mild liver enlargement, suggesting the heart and viscera weathered the ordeal far better than the locomotor system.

The gut microbiome proved a dynamic participant rather than a passive bystander. Bacterial alpha diversity—measured through richness, evenness, Shannon and Simpson indices—increased during and after the challenge compared with pre-run levels. Differential abundance analysis identified 21 taxa that changed significantly, including eight at the genus level. During the running months, Bifidobacterium, Pseudoscardovia, Fournierella and Coriobacteriaceae UCG-003 became more abundant, taxa associated with carbohydrate metabolism and short-chain fatty acid production—a plausible microbial response to a diet delivering about 10 grams of carbohydrate per kilogram daily, half of it simple sugars. During recovery, the picture shifted toward Akkermansia, the Eubacterium siraeum group and Lachnospiraceae-related genera, with Akkermansia’s enrichment detected consistently across phylum, class, order, family and genus levels. Given Akkermansia’s established associations with gut barrier integrity, metabolic regulation and anti-inflammatory effects, the authors suggest its rise during recovery reflects restoration of intestinal homeostasis after prolonged metabolic stress, and that extreme endurance exercise induces stable microbiome adaptations rather than temporary disruption.

The researchers are careful to note the limitations inherent in a single-participant design, which prevents generalisation, and to acknowledge that a baseline muscle biopsy was unavailable, that sleep and running economy went unmeasured, and that the athlete declined exercise testing during the challenge. Individual susceptibility to the dramatic creatine kinase elevations cannot be disentangled from the effect of the extreme load itself. Still, the study is, to the authors’ knowledge, the longest and largest ultra-endurance challenge ever scientifically monitored, and its central conclusion is sobering for anyone tempted to equate more running with better health. Sustaining roughly nine hours of daily running for over a year is physiologically feasible for a highly motivated, pain-tolerant individual with exceptional prior experience and a near-total predominance of type I muscle fibres—and adaptive changes in gut microbiota, testosterone and haematology appear to have supported completion.

But skeletal muscle emerged as the limiting factor. Reductions in muscle size, contractile capacity and mitochondrial content persisted far beyond the end of the running, with reactive strength still depressed a year and a half later. Most blood markers normalised within two to five months, strength returned within ten, yet explosive power lagged behind everything else. The trade-off documented here—a system optimised for endlessly repeated slow contractions at the expense of force and power—offers a rare, finely detailed portrait of human plasticity at its extremes, and a cautionary benchmark for how far the body can be bent before some capacities refuse to spring back.